Virtual Visits at Brigham and Women's Hospital

NCT ID: NCT03592355

Last Updated: 2021-09-22

Basic Information

• Recruitment Status: TERMINATED
• Clinical Phase: NA
• Total Enrollment: 77 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2018-04-13
• Study Completion Date: 2020-03-01

Brief Summary

Clinicians slated for virtual visit rollout will be randomized (stratified by department) to either receive immediate virtual visit on-boarding (intervention arm) or delayed (3-months later) virtual visit on-boarding (control arm). The investigators plan to enroll no more than 200 clinicians.

Any clinician in a department selected by the Brigham Health Virtual Care team for access to virtual visits is eligible, unless s/he saw less than 20 patients monthly over the last 6 months.

The Brigham Health Virtual Care team will onboard all clinicians and provide virtual visit support as per their usual protocol. The primary study endpoint is third-available appointment, a well-adopted measure of access. Other secondary endpoints revolve around continuity, efficiency, utilization, safety, cost, and patient experience.

Detailed Description

If enrolled in the intervention arm, the following steps will occur:

• The clinician will receive the intervention arm follow-up email ("Follow-up Email - Intervention" in the Appendix).
• The Brigham Health Virtual Care team will work with the clinician toward immediate on-boarding (software training, hardware setup, technical support) as per their usual process.
• The clinician will schedule virtual visits as s/he and/or her/his department see fit. Virtual visits occur on an already-in-use Partners- and Brigham-approved video platform (attached).

If enrolled in the control arm, the following steps will occur:

• The clinician will receive the control arm follow-up email ("Follow-up Email - Control" in the Appendix).
• Three months from the time of the follow-up email, the Brigham Health Virtual Care team will work with the clinician toward immediate on-boarding (software training, hardware setup, technical support) as per their usual process.
• The clinician will schedule virtual visits as s/he and/or her/his department see fit. Virtual visits occur on an already-in-use Partners- and Brigham-approved video platform (attached).

The investigators plan to follow patients of both clinician cohorts for a total of 6-months. The investigators will perform retrospective review of patient electronic health records and patients will receive a redcap survey (attached), an evaluation mechanism already employed by the Virtual Care team.

Again, aside from the initial randomization and retrospective data collection and analysis, all of the above would have occurred irrespective of this research protocol.

Conditions

Heart Failure; Hypertension; Diabetes Mellitus; Stroke; BPH; Hyperlipidemia

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

Intervention

If enrolled in the intervention arm, the following steps will occur:

• The Brigham Health Virtual Care team will work with the clinician toward immediate on-boarding (software training, hardware setup, technical support) as per their usual process.
• The clinician will schedule virtual visits as s/he and/or her/his department see fit. Virtual visits occur on an already-in-use Partners- and Brigham-approved video platform.

Group Type: EXPERIMENTAL

Virtual Visit

Intervention Type: OTHER

Clinicians will have a synchronous video visit with their patients.

Control

If enrolled in the control arm, the following steps will occur:

• Three months from the time of the follow-up email, the Brigham Health Virtual Care team will work with the clinician toward immediate on-boarding (software training, hardware setup, technical support) as per their usual process.
• The clinician will schedule virtual visits as s/he and/or her/his department see fit. Virtual visits occur on an already-in-use Partners- and Brigham-approved video platform.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Virtual Visit

Clinicians will have a synchronous video visit with their patients.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Clinician whose department is chosen for virtual visit rollout

Exclusion Criteria

• Clinician who saw on average fewer than 20 patients monthly over the past 6 months
• Clinician who opts out of virtual visits

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Brigham and Women's Hospital

OTHER

Sponsor Role: lead

Responsible Party

David Levine

Associate Physician

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

David Levine, MD, MPH, MA

Role: PRINCIPAL_INVESTIGATOR

Principal Investigator

Locations

Brigham and Women's Hospital

Boston, Massachusetts, United States

Countries

United States

References

Wootton R. Twenty years of telemedicine in chronic disease management--an evidence synthesis. J Telemed Telecare. 2012 Jun;18(4):211-20. doi: 10.1258/jtt.2012.120219.

Reference Type: BACKGROUND

PMID: 22674020 (View on PubMed)

McLean S, Sheikh A, Cresswell K, Nurmatov U, Mukherjee M, Hemmi A, Pagliari C. The impact of telehealthcare on the quality and safety of care: a systematic overview. PLoS One. 2013 Aug 19;8(8):e71238. doi: 10.1371/journal.pone.0071238. eCollection 2013.

Reference Type: BACKGROUND

PMID: 23977001 (View on PubMed)

Dorsey ER, Topol EJ. State of Telehealth. N Engl J Med. 2016 Jul 14;375(2):154-61. doi: 10.1056/NEJMra1601705. No abstract available.

Reference Type: BACKGROUND

PMID: 27410924 (View on PubMed)

Other Identifiers

2018P000452

Identifier Type: -

Identifier Source: org_study_id